The rise of the biosimilar

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Nov 2012 English Publisher:Informa UK LimitedJournal:Expert Review of Clinical Pharmacology, volume 5, pages 597-599 (issn: 1751-2433, eissn: 1751-2441,

Copyright policy )

Authors: Mark, McCamish; Gillian, Woollett;

doi: 10.1586/ecp.12.60

pmid: 23234317

The rise of the biosimilar

- Summary
- Subjects
- Metrics

Abstract

Recombinant biologics have had an incredible impact on diseases such as arthritis and cancer by targeting specific receptors or disease mediators; however, access to these drugs is increasingly lim...

Keywords

Biological Products, Therapeutic Equivalency, Humans, Biosimilar Pharmaceuticals

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	12
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%